| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.28 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.02 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.27 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |